Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
19.06
-0.91 (-4.56%)
At close: Jan 8, 2026, 4:00 PM EST
19.39
+0.33 (1.73%)
After-hours: Jan 8, 2026, 7:43 PM EST
Surrozen Market Cap
Surrozen has a market cap or net worth of $163.37 million as of January 8, 2026. Its market cap has increased by 409.33% in one year.
Market Cap
163.37M
Enterprise Value
89.12M
1-Year Change
409.33%
Ranking
Category
Stock Price
$19.06
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $163.37M, an increase of 35.41%. That is a compound annual growth rate of 6.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 171.17M | -11.64% |
| Dec 31, 2025 | 193.71M | 315.39% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | 120.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |